CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-08 | Kramer Robert President and CEO | Option exercise | +13,000 | $30.63 | $398K | 152,210 |
| 2021-02-08 | Kramer Robert President and CEO | Sale | −13,000 | $120.03 | $1.6M | 139,210 |
| 2021-02-08 | Kramer Robert President and CEO | Option exercise · Employee Stock Options (Right to Buy) | −32,397 | $120.03 | $3.9M | 0 |
| 2021-02-08 | Kramer Robert President and CEO | Option exercise · Employee Stock Options (Right to Buy) | −13,000 | $120.03 | $1.6M | 19,638 |
| 2021-01-21 | Kramer Robert President and CEO | Option exercise | +21,900 | $26.45 | $579K | 161,110 |
| 2021-01-21 | Kramer Robert President and CEO | Sale | −21,900 | $110.03 | $2.4M | 139,210 |
| 2021-01-21 | Kramer Robert President and CEO | Option exercise · Employee Stock Options (Right to Buy) | −21,900 | $110.03 | $2.4M | 0 |
| 2021-01-20 | Kramer Robert President and CEO | Option exercise | +2,232 | $26.45 | $59K | 141,442 |
| 2021-01-20 | Kramer Robert President and CEO | Sale | −2,232 | $110.00 | $246K | 139,210 |
| 2021-01-20 | Kramer Robert President and CEO | Option exercise · Employee Stock Options (Right to Buy) | −2,232 | $110.00 | $246K | 21,900 |
| 2021-01-15 | Kramer Robert President and CEO | Option exercise | +19,026 | $25.62 | $487K | 158,236 |
| 2021-01-15 | Kramer Robert President and CEO | Sale | −19,026 | $106.01 | $2.0M | 139,210 |
| 2021-01-15 | Kramer Robert President and CEO | Option exercise · Employee Stock Options (Right to Buy) | −19,026 | 0 | ||
| 2020-11-10 | El-Hibri Fuad Chairman | Option exercise | +19,391 | $26.45 | $513K | 1,143,379 |
| 2020-11-10 | El-Hibri Fuad Chairman | Sale | −19,391 | $88.21 | $1.7M | 1,123,988 |
| 2020-11-10 | El-Hibri Fuad Chairman | Option exercise · Stock Options (Right to Buy) | −19,391 | 0 | ||
| 2020-11-09 | El-Hibri Fuad Chairman | Option exercise | +20,000 | $26.45 | $529K | 1,143,988 |
| 2020-11-09 | El-Hibri Fuad Chairman | Sale | −20,000 | $95.26 | $1.9M | 1,123,988 |
| 2020-11-09 | El-Hibri Fuad Chairman | Option exercise · Stock Options (Right to Buy) | −20,000 | 19,391 | ||
| 2020-11-03 | El-Hibri Fuad Chairman | Option exercise | +20,000 | $26.45 | $529K | 1,143,988 |
Page 22 of 31 · 601 trades